Late Phase Research

Late Phase Research and Real World Evidence

We help you plan early for long-term commercial success, helping you to mitigate risk and establish evidence.
Get In Touch
Late Phase Research

Accelerated approvals put more pressure on regulatory, risk management, and risk mitigation strategies.

The need has never been greater for healthcare companies to be diligent when it comes to late-phase or peri-approval research. Cerner Enviza ℠ has more than 30 years of clinical research experience and can design a customized study to meet the needs of your product or research area. Our solutions enable you to adhere to risk management requirements, establish evidence for safety issues, and assess health outcomes and economics in various settings.

Featured solutions

Integrated Data from Cerner Enviza Linked Data

Understand the patient’s disease journey with more clarity by linking at the patient level Cerner Enviza EHR and Claims data, as well as Cerner Enviza’s National Health and Wellness Study.
Learn More

Health Economics and Outcomes Research (HEOR)

Get comprehensive research and data to evaluate patient outcomes, treatment patterns, resource utilization, and costs.
Learn More

Epidemiology

Accurate and holistic analysis on the incidence, distribution, and control of diseases and factors relating to health.
Learn More

Client Results

Early value

Generate evidence to tell a compelling value story about the safety and effectiveness of your treatment.

Post-marketing

Build knowledge and gather evidence early for new indications, scientific differentiation and product positioning.

Evidence

Satisfy regulatory requirements to prove your product is safe and that benefits of treatment outweigh the risks.